Variant report

Variant	nsv1039081
Chromosome Location	chr12:30320388-30410076
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:263)
CpG islands
(count:733)
Chromatin interactive
region (count:12)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:263 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr12:30322887-30323245	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr12:30350425-30350895	H1-hESC	embryonic stem cell:	n/a	n/a
3	BATF	chr12:30392480-30392665	GM12878	blood:	n/a	chr12:30392574-30392585
4	CEBPB	chr12:30361651-30361976	IMR90	lung:	n/a	chr12:30361791-30361802
5	CEBPB	chr12:30390833-30391122	HepG2	liver:	n/a	chr12:30390970-30390981
6	CEBPB	chr12:30361766-30361910	K562	blood:	n/a	chr12:30361791-30361802
7	CEBPB	chr12:30363875-30364075	K562	blood:	n/a	chr12:30363953-30363964
8	CEBPB	chr12:30363864-30364111	HepG2	liver:	n/a	chr12:30363953-30363964
9	CEBPB	chr12:30377310-30377513	A549	lung:	n/a	chr12:30377386-30377397
10	CEBPB	chr12:30351134-30351189	HepG2	liver:	n/a	n/a
11	CEBPB	chr12:30355896-30356101	HepG2	liver:	n/a	n/a
12	CEBPB	chr12:30361704-30361917	A549	lung:	n/a	chr12:30361791-30361802
13	CEBPB	chr12:30377254-30377495	HepG2	liver:	n/a	chr12:30377386-30377397
14	CEBPB	chr12:30361676-30361926	HepG2	liver:	n/a	chr12:30361791-30361802
15	CEBPB	chr12:30363917-30364012	A549	lung:	n/a	chr12:30363953-30363964
16	CEBPB	chr12:30360483-30360805	HepG2	liver:	n/a	chr12:30360641-30360652
17	CHD2	chr12:30323346-30323475	H1-hESC	embryonic stem cell:	n/a	n/a
18	CTBP2	chr12:30322662-30323667	H1-hESC	embryonic stem cell:	n/a	n/a
19	CTCF	chr12:30330560-30330710	AG09319	gingival:	n/a	n/a
20	CTCF	chr12:30391620-30391770	HCFaa	heart:	n/a	n/a
21	CTCF	chr12:30391722-30391922	K562	blood:	n/a	chr12:30391781-30391799
22	CTCF	chr12:30377109-30377202	GM20000	blood:	n/a	n/a
23	CTCF	chr12:30391760-30391910	HCM	heart:	n/a	chr12:30391781-30391799
24	CTCF	chr12:30391760-30391910	HA-sp	spinal cord:	n/a	chr12:30391781-30391799
25	CTCF	chr12:30354375-30354507	Spleen_OC	spleen:	n/a	n/a
26	CTCF	chr12:30330740-30330890	HPAF	blood vessel:	n/a	n/a
27	CTCF	chr12:30391640-30391790	HCT-116	colon:	n/a	n/a
28	CTCF	chr12:30391680-30391830	HMF	breast:	n/a	chr12:30391781-30391799
29	CTCF	chr12:30354420-30354570	HCFaa	heart:	n/a	n/a
30	CTCF	chr12:30354380-30354530	HCPEpiC	choroid plexus:	n/a	n/a
31	CTCF	chr12:30391720-30391870	HPAF	blood vessel:	n/a	chr12:30391781-30391799
32	CTCF	chr12:30354340-30354490	HMF	breast:	n/a	n/a
33	CTCF	chr12:30330740-30330890	HCPEpiC	choroid plexus:	n/a	n/a
34	CTCF	chr12:30391617-30391890	IMR90	lung:	n/a	chr12:30391781-30391799
35	CTCF	chr12:30330749-30330916	Medullo	brain:	n/a	n/a
36	CTCF	chr12:30330660-30330810	HBMEC	blood vessel:	n/a	n/a
37	CTCF	chr12:30391660-30391810	AG04450	lung:	n/a	chr12:30391781-30391799
38	CTCF	chr12:30354340-30354490	HMEC	breast:	n/a	n/a
39	CTCF	chr12:30391800-30391950	AG09319	gingival:	n/a	n/a
40	CTCF	chr12:30391640-30391790	BJ	skin:	n/a	n/a
41	CTCF	chr12:30391700-30391850	GM06990	blood:	n/a	chr12:30391781-30391799
42	CTCF	chr12:30391680-30391830	GM12873	blood:	n/a	chr12:30391781-30391799
43	CTCF	chr12:30354399-30354577	IMR90	lung:	n/a	n/a
44	CTCF	chr12:30379648-30379698	GM10248	blood:	n/a	n/a
45	CTCF	chr12:30380614-30380652	ProgFib	skin:	n/a	n/a
46	CTCF	chr12:30391642-30391946	GM12878	blood:	n/a	chr12:30391781-30391799
47	CTCF	chr12:30354404-30354500	H1-hESC	embryonic stem cell:	n/a	n/a
48	CTCF	chr12:30391700-30391850	HMF	breast:	n/a	chr12:30391781-30391799
49	CTCF	chr12:30391680-30391830	AG09319	gingival:	n/a	chr12:30391781-30391799
50	CTCF	chr12:30391640-30391790	Caco-2	colon:	n/a	n/a

(count:733 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:30351139-30351189	MCF-7	breast:	n/a
2	chr12:30351139-30351189	MCF-7	breast:	n/a
3	chr12:30323676-30323726	SKMC	muscle:	n/a
4	chr12:30322864-30322914	HNPCEpiC	eye:	n/a
5	chr12:30354663-30354713	HCPEpiC	choroid plexus:	n/a
6	chr12:30323251-30323301	RPTEC	kidney:	n/a
7	chr12:30325938-30325988	H1-hESC	embryonic stem cell:	embryo
8	chr12:30354611-30354661	HPAEpiC	pulmonary alveolar:	n/a
9	chr12:30357109-30357159	HAEpiC	amniotic membrane:	n/a
10	chr12:30325938-30325988	MCF10A-Er-Src	breast:	n/a
11	chr12:30354142-30354192	HCPEpiC	choroid plexus:	n/a
12	chr12:30354246-30354296	GM12878	blood:	n/a
13	chr12:30323676-30323726	GM19239	blood:	n/a
14	chr12:30351139-30351189	GM12892	blood:	n/a
15	chr12:30354611-30354661	AG09319	gingival:	n/a
16	chr12:30323676-30323726	HIPEpiC	eye:	n/a
17	chr12:30322864-30322914	HAEpiC	amniotic membrane:	n/a
18	chr12:30322864-30322914	RPTEC	kidney:	n/a
19	chr12:30354663-30354713	HIPEpiC	eye:	n/a
20	chr12:30354142-30354192	ProgFib	skin:	n/a
21	chr12:30323676-30323726	SK-N-MC	brain:	n/a
22	chr12:30323251-30323301	HCPEpiC	choroid plexus:	n/a
23	chr12:30354663-30354713	SK-N-SH	brain:	n/a
24	chr12:30354663-30354713	PrEC	prostate:	n/a
25	chr12:30354246-30354296	HEK293	kidney:	embryo
26	chr12:30351139-30351189	HIPEpiC	eye:	n/a
27	chr12:30357109-30357159	ovcar-3	ovarian:	n/a
28	chr12:30354246-30354296	NB4	blood:	n/a
29	chr12:30323251-30323301	HepG2	liver:	n/a
30	chr12:30354246-30354296	HEEpiC	esophagus:	n/a
31	chr12:30357109-30357159	Hepatocyte	liver:	n/a
32	chr12:30322730-30322780	IMR90	lung:	fetal
33	chr12:30354246-30354296	GM19239	blood:	n/a
34	chr12:30351139-30351189	K562	blood:	n/a
35	chr12:30323251-30323301	HCM	heart:	n/a
36	chr12:30354663-30354713	HUVEC	blood vessel:	n/a
37	chr12:30354611-30354661	HIPEpiC	eye:	n/a
38	chr12:30357109-30357159	GM12878	blood:	n/a
39	chr12:30323251-30323301	AG09309	skin:	n/a
40	chr12:30351139-30351189	GM12891	blood:	n/a
41	chr12:30322864-30322914	Hela-S3	cervix:	n/a
42	chr12:30325938-30325988	HRPEpiC	eye:	n/a
43	chr12:30354663-30354713	SAEC	small airway:	n/a
44	chr12:30323676-30323726	SK-N-SH	brain:	n/a
45	chr12:30325938-30325988	AG09319	gingival:	n/a
46	chr12:30323251-30323301	ECC-1	luminal epithelium:	n/a
47	chr12:30354142-30354192	HRCEpiC	kidney:	n/a
48	chr12:30325938-30325988	HepG2	liver:	n/a
49	chr12:30323676-30323726	NT2-D1	testis:	n/a
50	chr12:30351139-30351189	NHDF-neo	bronchial:	n/a

(count:12 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:30394846..30396422-chr12:30402248..30404623,2	K562	blood:
2	chr12:30354231..30355981-chr12:30359354..30362210,2	K562	blood:
3	chr12:30375754..30378220-chr12:30379404..30381460,2	K562	blood:
4	chr12:30354231..30355981-chr12:30359354..30362210,2	K562	blood:
5	chr12:30388256..30390909-chr12:30391939..30394799,2	K562	blood:
6	chr12:30375754..30378220-chr12:30379404..30381460,2	K562	blood:
7	chr12:30388256..30390909-chr12:30391939..30394799,2	K562	blood:
8	chr12:30351001..30353432-chr12:30354481..30356033,2	MCF-7	breast:
9	chr12:30394846..30396422-chr12:30402248..30404623,2	K562	blood:
10	chr12:30345156..30347893-chr12:30349576..30351701,2	MCF-7	breast:
11	chr12:30345156..30347893-chr12:30349576..30351701,2	MCF-7	breast:
12	chr12:30351001..30353432-chr12:30354481..30356033,2	MCF-7	breast:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-IPO8-1	chr12:30385709-30385793	ENSG00000257756
2	lnc-IPO8-1	chr12:30383718-30383968	ENSG00000257756
3	lnc-IPO8-1	chr12:30397268-30397338	ENSG00000257756
4	lnc-TSPAN11-5	chr12:30353916-30354041	ENSG00000257262
5	lnc-TSPAN11-5	chr12:30361375-30361505	ENSG00000257262
6	lnc-TSPAN11-5	chr12:30370536-30370849	ENSG00000257262

No data

Variant related genes	Relation type
ENSG00000257262	TF binding region
ENSG00000257262	CpG island

Extended variants
information (count: 1374 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:1374 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs550349054	chr12:30321479-30321480	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs562327733	chr12:30321509-30321510	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs574100988	chr12:30321582-30321583	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs6487883	chr12:30321589-30321590	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs372290070	chr12:30321655-30321656	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs563162945	chr12:30321673-30321674	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs11050702	chr12:30321713-30321714	Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs551786139	chr12:30321715-30321716	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs560482375	chr12:30321744-30321745	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs564143593	chr12:30321759-30321760	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs144895513	chr12:30321805-30321806	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs567464351	chr12:30321825-30321826	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs11050703	chr12:30321840-30321841	Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs112411789	chr12:30321912-30321913	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs11050704	chr12:30321950-30321951	Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs538281514	chr12:30321971-30321972	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs11050705	chr12:30321975-30321976	Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs79269267	chr12:30322034-30322035	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
19	rs17457272	chr12:30322040-30322041	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs185687154	chr12:30322042-30322043	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
21	rs544459925	chr12:30322046-30322047	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
22	rs556932876	chr12:30322082-30322083	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
23	rs578254495	chr12:30322112-30322113	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
24	rs545691066	chr12:30322166-30322167	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
25	rs12368624	chr12:30322208-30322209	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs12371944	chr12:30322219-30322220	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs543148957	chr12:30322232-30322233	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
28	rs11837135	chr12:30322239-30322240	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs556292743	chr12:30322240-30322241	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
30	rs142227948	chr12:30322276-30322277	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
31	rs377751919	chr12:30322300-30322301	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
32	rs561272980	chr12:30322374-30322375	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
33	rs571074198	chr12:30322397-30322398	Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
34	rs577934531	chr12:30322410-30322411	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
35	rs532293898	chr12:30322431-30322432	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
36	rs151214405	chr12:30322471-30322472	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
37	rs565343809	chr12:30322476-30322477	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
38	rs141362224	chr12:30322485-30322486	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
39	rs531463089	chr12:30322530-30322531	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
40	rs146978737	chr12:30322599-30322600	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
41	rs569638253	chr12:30322628-30322629	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
42	rs147913512	chr12:30322723-30322724	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
43	rs556820264	chr12:30322765-30322766	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
44	rs141640308	chr12:30322809-30322810	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs1968879	chr12:30322860-30322861	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs554497717	chr12:30322862-30322863	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs572552705	chr12:30322864-30322865	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs572451203	chr12:30322879-30322880	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs190056862	chr12:30322946-30322947	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs113010884	chr12:30323040-30323041	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Myxofibrosarcoma	16751306	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Acute myeloid leukemia	16864856	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Acute myeloid leukemia	21251322	CNVD
small cell lung cancer	20016488	CNVD
Neurodevelopmental disorder	22521361	CNVD
Breast cancer	21509527	CNVD
Follicular lymphoma	18703704	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Breast cancer	17133270	CNVD
Cancer	21129771	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17899364	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	22522925	CNVD
Glioma	20126413	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:290 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:30321400-30322000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
2	chr12:30321600-30322200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
3	chr12:30321800-30322000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
4	chr12:30322000-30322400	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
5	chr12:30322000-30322400	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
6	chr12:30322000-30322600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
7	chr12:30322000-30322600	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
8	chr12:30322000-30322800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
9	chr12:30322200-30322400	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
10	chr12:30322200-30322400	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr12:30322200-30322400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
12	chr12:30322200-30322800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
13	chr12:30322400-30323000	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr12:30322400-30323600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
15	chr12:30322400-30323800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
16	chr12:30322600-30322800	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
17	chr12:30322600-30323200	Bivalent/Poised TSS	Right Ventricle	heart
18	chr12:30322600-30323600	Active TSS	H9 Cell Line	embryonic stem cell
19	chr12:30322600-30323600	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
20	chr12:30322600-30323800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
21	chr12:30322600-30323800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
22	chr12:30322800-30323000	Flanking Bivalent TSS/Enh	iPS DF 6.9 Cell Line	embryonic stem cell
23	chr12:30322800-30323200	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
24	chr12:30322800-30323200	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
25	chr12:30322800-30323200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
26	chr12:30322800-30323200	Bivalent Enhancer	Left Ventricle	heart
27	chr12:30322800-30323400	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
28	chr12:30322800-30323600	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
29	chr12:30322800-30323600	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
30	chr12:30322800-30323600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
31	chr12:30322800-30323600	Bivalent Enhancer	Lung	lung
32	chr12:30322800-30323600	Enhancers	Pancreas	Pancrea
33	chr12:30322800-30323800	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
34	chr12:30322800-30323800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
35	chr12:30323000-30323200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
36	chr12:30323000-30323200	Bivalent/Poised TSS	Fetal Brain Female	brain
37	chr12:30323000-30323200	Bivalent/Poised TSS	Fetal Stomach	stomach
38	chr12:30323000-30323200	Bivalent/Poised TSS	Psoas Muscle	Psoas
39	chr12:30323000-30323400	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
40	chr12:30323000-30323400	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr12:30323000-30323400	Bivalent/Poised TSS	Cortex derived primary cultured neurospheres	brain
42	chr12:30323000-30323400	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
43	chr12:30323000-30323400	Bivalent Enhancer	Esophagus	oesophagus
44	chr12:30323000-30323400	Active TSS	Right Atrium	heart
45	chr12:30323000-30323600	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
46	chr12:30323000-30323600	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
47	chr12:30323000-30323600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
48	chr12:30323000-30323600	Bivalent Enhancer	Fetal Muscle Leg	muscle
49	chr12:30323200-30323400	Bivalent/Poised TSS	Breast Myoepithelial Primary Cells	Breast
50	chr12:30323200-30323400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links